Targeting costimulatory molecules to improve antitumor immunity.
about
Overview of current immunotherapeutic strategies for gliomaDendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trialsGenetically modified T cells in cancer therapy: opportunities and challengesDendritic Cell-Based Immunotherapy Treatment for Glioblastoma MultiformeSoluble co-signaling molecules predict long-term graft outcome in kidney-transplanted patientsClinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go.Evaluation of Costimulatory Molecules in Peripheral Blood Lymphocytes of Canine Patients with Histiocytic Sarcoma.Parapharyngeal liposarcoma: a case report.The Application of Cytidyl Guanosyl Oligodeoxynucleotide Can Affect the Antitumor Immune Response Induced by a Combined Protocol of Cryoablation and Dendritic Cells in Lewis Lung Cancer Model.Ctla-4 expression and polymorphisms in lung tissue of patients with diagnosed non-small-cell lung cancer.Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging.Various ways to improve whole cancer cell vaccines.Nivolumab in combination with ipilimumab for the treatment of melanoma.Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.No patient left behind: The promise of immune priming with epigenetic agents.Targeting Autocrine CCL5-CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity.Antibody-cytokine fusion proteins for cancer immunotherapy: an update on recent developments.Current Strategies to Enhance Anti-Tumour Immunity.B7-H6 protein expression has no prognostic significance in human gastric carcinoma.
P2860
Q26776345-1874E122-4F91-4A47-A7A7-461495957BEFQ27014829-B492BEC0-3B7B-4A6C-A0DB-A630F1FEB78EQ27026627-2DF9C139-D242-499F-93B7-05921D870108Q28087485-B86CEE7F-55AA-4A7B-93B5-FC9B374F7A05Q34639457-FEF925FF-0A9C-4D53-BF38-B814BCF9BDC2Q34658452-57660410-4F15-47B3-8DA4-9A51BCC7CEE2Q35931188-AB43E648-2BA6-4B3E-88E6-49EF60CFCB35Q36690223-780F4AA8-8F3B-49A6-9BA4-29503FAD6D4EQ36820908-3AFCAFB9-DC7A-4931-8E97-62D61A430938Q37044252-0C3DF8F5-7DF4-4E33-B353-B168C64972F7Q37600688-69722A71-512F-477B-AB1C-198A3C7091D5Q38206582-278CB4A1-1532-43A8-A954-E49A1132A078Q38592160-1EFB344A-7B87-4223-84C1-C6005BCD04BFQ38810926-F96E4092-9CF3-4EC3-BE6B-2F99AF8A8399Q40217706-892DA439-E36B-4049-9B54-C763C2CADCEEQ46665179-EAF1622A-7099-4DC5-AC8F-8AF8DF362EF6Q50443511-42596496-4D47-4FF9-898F-B2F09532A85EQ51786117-20A468BB-C556-4AB9-8D19-0ACDCBFF6449Q52344613-146056CD-E282-48FE-B059-23EA310FE587Q54586743-FC4220B6-FD00-4E49-98AA-C08E9F64731A
P2860
Targeting costimulatory molecules to improve antitumor immunity.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting costimulatory molecules to improve antitumor immunity.
@en
type
label
Targeting costimulatory molecules to improve antitumor immunity.
@en
prefLabel
Targeting costimulatory molecules to improve antitumor immunity.
@en
P2093
P2860
P921
P356
P1476
Targeting costimulatory molecules to improve antitumor immunity
@en
P2093
Daniela Verzella
Daria Capece
Edoardo Alesse
Mariafausta Fischietti
P2860
P304
P356
10.1155/2012/926321
P577
2012-02-12T00:00:00Z